Clinical Trials Logo

Filter by:
NCT ID: NCT01203085 Recruiting - Clinical trials for Charcot Marie Tooth Disease

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

INC-6603
Start date: April 2010
Phase:
Study type: Observational

The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.

NCT ID: NCT01198288 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Start date: September 2010
Phase: Phase 3
Study type: Interventional

This study will investigate if adding a domiciliary respiratory physiotherapy treatment to standard care in patients with chronic obstructive pulmonary disease (COPD) can improve physical function (walking test) and quality of life.

NCT ID: NCT01193088 Recruiting - HMSN Clinical Trials

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

INC-6602
Start date: May 2010
Phase:
Study type: Observational

This project includes two projects. One is looking for new genes that cause Charcot Marie Tooth disease (CMT). The other is looking for genes that do not cause CMT, but may modify the symptoms a person has.

NCT ID: NCT01193075 Recruiting - Clinical trials for Charcot Marie Tooth Disease

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

INC-6601
Start date: April 1, 2010
Phase:
Study type: Observational

This is an observational longitudinal study to determine the natural history and genotype-phenotype correlations of disease causing mutations in Charcot Marie Tooth disease (CMT) type 1B (CMT1B), 2A (CMT2A), 4A (CMT4A), and 4C (CMT4C). The investigators will also be determine the capability of the newly developed CMT Pediatric Scale (CMT Peds scale) and the Minimal Dataset to measure impairment and perform longitudinal measurements in patients with multiple forms of CMT over a five year window

NCT ID: NCT01192711 Recruiting - Type 1 Diabetes Clinical Trials

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

DID3
Start date: May 2009
Phase: Phase 3
Study type: Interventional

The Diabetes Interactive Diary (DID) is both a CHO (carbohydrates )/insulin bolus calculator, an information technology and a telemedicine system based on the communication between health care professional and patient by SMS messages. Aim of the study is to compare an insulin regimen of insulin glargine + prandial insulin glulisine associated with a telemedicine system to teach CHO counting (DID) with the same insulin regimen administered according to usual practice.

NCT ID: NCT01173666 Recruiting - Clinical trials for Left Ventricular Hypertrophy

Stenting of Renal Artery Stenosis in Coronary Artery Disease Study

RASCAD
Start date: April 2006
Phase: Phase 3
Study type: Interventional

The Stenting of Renal Artery Stenosis in Coronary Artery Disease (RASCAD) study is a randomized controlled trial designed to evaluate the effect of renal artery stenting+medical therapy versus medical therapy alone on left ventricular mass progression and cardiovascular morbidity and mortality in patients affected by coronary artery disease and renal artery stenosis.

NCT ID: NCT01172912 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

Start date: October 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. An autologous stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy. PURPOSE: This phase II trial is studying the side effects of giving high-dose chemotherapy together with stem cell transplant and to see how well it works in treating patients with metastatic germ cell tumors that have not responded to first-line therapy.

NCT ID: NCT01172886 Recruiting - Clinical trials for Metabolic Syndrome as Breast Cancer Risk Factor

Metabolic Syndrome as Modifiable Risk Factor for Breast Cancer

Start date: January 2008
Phase: N/A
Study type: Observational

Healthy women and women with breast cancer have been enrolled in our nested case-control study between 2008 and 2009 in order to evaluate the association between metabolic syndrome and breast cancer, analyzing anthropometric parameters blood pressure, assessing serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease. Our data support the hypothesis that metabolic syndrome may be an indicator of breast cancer risk in postmenopausal women. The change of the hormonal arrangement in postmenopausal, along with an increase in visceral adiposity, probably favour the hormone dependent cell proliferation, which drives tumorigenesis. Adjustments in lifestyle with physical activity intensification and healthy diet may represent modifiable factors on which sporadic breast cancer primary prevention may work on.

NCT ID: NCT01171807 Recruiting - Ulcerative Colitis Clinical Trials

Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis

Crocodex
Start date: April 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of erythrocyte-mediated delivery of dexamethasone in steroid-dependent ulcerative colitis patients

NCT ID: NCT01168154 Recruiting - Diverticulitis Clinical Trials

Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease

ReDiCo
Start date: February 2009
Phase: Phase 3
Study type: Interventional

The aim of this study is to evaluate the effectiveness and the tolerability of the Lactobacillus reuteri in the control of the diverticular disease symptoms and in the prevention of acute diverticulitis episodes.